Which treatment is better? Ascertaining patient preferences with crossover randomized controlled trials

Journal of Pain and Symptom Management

Volumn 49, Issue 3, 2015, Pages 625-631

  Hui, David ^a   Zhukovsky, Donna S ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Clinical trials; crossover studies; palliative care; randomized controlled trial; research design; statistical data interpretation

Indexed keywords

ARTICLE; ASCERTAINMENT BIAS; CLINICAL PRACTICE; COST CONTROL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEASIBILITY STUDY; HUMAN; META ANALYSIS (TOPIC); MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PARALLEL DESIGN; PATIENT PREFERENCE; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; STRATIFICATION; STUDY DESIGN; METHODOLOGY; PROCEDURES;

CROSS-OVER STUDIES; HUMANS; PALLIATIVE CARE; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84924611677     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.11.294     Document Type: Article

References (35)

1. D. Hui, H.A. Parsons, and S. Damani Quantity, design, and scope of the palliative oncology literature Oncologist 16 2011 694 703
2. D. Hui, J. Arthur, S. Dalal, and E. Bruera Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials Support Care Cancer 20 2012 1779 1785
3. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status. ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415
4. G. Wells, D. Beaton, and B. Shea Minimal clinically important differences: review of methods J Rheumatol 28 2001 406 412
5. A.G. Copay, B.R. Subach, S.D. Glassman, D.W. Polly Jr., and T.C. Schuler Understanding the minimum clinically important difference: a review of concepts and methods Spine J 7 2007 541 546
6. D.A. Redelmeier, G.H. Guyatt, and R.S. Goldstein Assessing the minimal important difference in symptoms: a comparison of two techniques J Clin Epidemiol 49 1996 1215 1219
7. D. Hui, and E. Bruera Minimal clinically important differences in the Edmonton Symptom Assessment System: the anchor is key J Pain Symptom Manage 45 2013 e4 e5
8. S.I. Rennard Minimal clinically important difference, clinical perspective: an opinion COPD 2 2005 51 55
9. C. Mazzocato, C. Sweeney, and E. Bruera Clinical research in palliative care: choice of trial design Palliat Med 15 2001 261 264
10. S. Wellek, and M. Blettner On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications Dtsch Arztebl Int 109 2012 276 281
11. J.E. Margarone, C. Liebow, R.E. Hall, R.E. Braun, and M. Weiner A comparison of crossover versus parallel-group design in the evaluation of analgesic efficacy after molar extraction Clin Pharmacol Ther 58 1995 453 458
12. D. Hui, A. Reddy, H.A. Parsons, and E. Bruera Reporting of funding sources and conflict of interest in the supportive and palliative oncology literature J Pain Symptom Manage 44 2012 421 430
13. M. Hagedoorn, K.C. Sneeuw, and N.K. Aaronson Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one's condition J Clin Epidemiol 55 2002 176 183
14. J.S. Howard, C.G. Mattacola, D.M. Howell, and C. Lattermann Response shift theory: an application for health-related quality of life in rehabilitation research and practice J Allied Health 40 2011 31 38
15. J.N. Matthews Multi-period crossover trials Stat Methods Med Res 3 1994 383 405
16. J.E. Grizzle The two-period change-over design and its use in clinical trials Biometrics 2 1965 469 480
17. A.R. Willan, and J.L. Pater Carryover and the two-period crossover clinical trial Biometrics 42 1986 593 599
18. P.C. O'Brien The use and misuse of N-of-one studies Int J Oral Maxillofac Implants 12 1997 293
19. S. Vohra, and S. Punja N-of-1 trials: individualized medication effectiveness tests Virtual Mentor 15 2013 42 45
20. N. Duan, R.L. Kravitz, and C.H. Schmid Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research J Clin Epidemiol 66 2013 S21 S28
21. N.B. Gabler, N. Duan, S. Vohra, and R.L. Kravitz N-of-1 trials in the medical literature: a systematic review Med Care 49 2011 761 768
22. C.C. Cushing, R.W. Walters, and L. Hoffman Aggregated N-of-1 randomized controlled trials: modern data analytics applied to a clinically valid method of intervention effectiveness J Pediatr Psychol 39 2014 138 150
23. P. Sedgwick What is an "n-of-1" trial? BMJ 348 2014 g2674
24. E. Bruera, T. Schoeller, and T. MacEachern Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N-of-1 randomized controlled trial J Pain Symptom Manage 7 1992 365 368
25. J. Nikles, G. Mitchell, and J. Walters Prioritising drugs for single patient (n-of-1) trials in palliative care Palliat Med 23 2009 623 634
26. M. Farquhar, I.J. Higginson, and S. Booth Fast-track trials in palliative care: an alternative randomized controlled trial design J Palliat Med 12 2009 213
27. H.M. Siddons, A.C. Wootten, and A.J. Costello A randomised, wait-list controlled trial: evaluation of a cognitive-behavioural group intervention on psycho-sexual adjustment for men with localised prostate cancer Psychooncology 22 2013 2186 2192
28. K.A. Zernicke, T.S. Campbell, and M. Speca A randomized wait-list controlled trial of feasibility and efficacy of an online mindfulness-based cancer recovery program: the eTherapy for cancer applying mindfulness trial Psychosom Med 76 2014 257 267
29. T.A. Furukawa, H. Noma, and D.M. Caldwell Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis Acta Psychiatr Scand 130 2014 181 192
30. E. Bruera, S. Carraro, E. Roca, M. Barugel, and R. Chacon Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients Cancer Treat Rep 70 1986 295 298
31. E. Bruera, N. de Stoutz, A. Velasco-Leiva, T. Schoeller, and J. Hanson Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients Lancet 342 1993 13 14
32. D. Hui, M. Morgado, and G. Chisholm High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial J Pain Symptom Manage 46 2013 463 473
33. E. Bruera, J.L. Palmer, and E. Pace A randomized, controlled trial of physician postures when breaking bad news to cancer patients Palliat Med 21 2007 501 505
34. F. Strasser, J.L. Palmer, and J. Willey Impact of physician sitting versus standing during inpatient oncology consultations: patients' preference and perception of compassion and duration. A randomized controlled trial J Pain Symptom Manage 29 2005 489 497
35. W. Rhondali, P. Perez-Cruz, and D. Hui Patient-physician communication about code status preferences: a randomized controlled trial Cancer 119 2013 2067 2073